← All organizations

Orphan Therapeutics

For profitWebsite ↗

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Jun 1, 2004

Timeline

2000s

Jun 1, 2003
Orphan Therapeutics— Founded

Drugs by trial phase (1 distinct, 1 trials)

Phase 3 (1 own, 0 via acquisition)

terlipressin

Indications

Studied for

Recent trials (2)

NCT00089570Study directorPhase 3Jun 1, 2004
NCT00089570Lead sponsorPhase 3Jun 1, 2004

Details

Founded: Lebanon, NJ, US Jun 1, 2003
Last known activity: Jun 1, 2004